We are live on ! Find out more
ZOM

Zomedica Corp.
ZOM

Delisted

ZOM was delisted on the 4th of March, 2025.

Back to rankings

16 hedge funds and large institutions have $2.43M invested in Zomedica Corp. in 2020 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

24% less funds holding

Funds holding: 21 → 16 (-5)

25% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 4

42% less capital invested

Capital invested by funds: $4.21M → $2.43M (-$1.79M)

67% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 6

Holders
16
Holders Change
-5
Holders Change %
-23.81%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
3
Reduced
4
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors
Iowa
+$41.7K
2
Victory Capital Management
Victory Capital Management
Texas
+$5.55K
3
UBS Group
UBS Group
Switzerland
+$5.48K
4
RIS
Retirement Income Solutions
Michigan
+$1.23K

Top Sellers

Rank Fund Capital Flow
1
SG Americas Securities
SG Americas Securities
New York
-$20K
2
Citadel Advisors
Citadel Advisors
Florida
-$11.3K
3
Wells Fargo
Wells Fargo
California
-$9K
4
IP
Isthmus Partners
Wisconsin
-$7.74K
5
Citigroup
Citigroup
New York
-$2K
Name Holding Trade Value Shares
Change 		Change in
Stake
Cambridge Investment Research Advisors
1
Cambridge Investment Research Advisors
Iowa
$2.33M +$41.7K +181,000 +1%
Vanguard Group
2
Vanguard Group
Pennsylvania
$56K – – –
JA
3
JVL Associates
Michigan
$11K – – –
UBS Group
4
UBS Group
Switzerland
$10K +$5.48K +23,808 +90%
IP
5
Isthmus Partners
Wisconsin
$6K -$7.74K -33,600 -52%
RIS
6
Retirement Income Solutions
Michigan
$6K +$1.23K +5,357 +20%
Victory Capital Management
7
Victory Capital Management
Texas
$4K +$5.55K +24,110 New
Citadel Advisors
8
Citadel Advisors
Florida
$3K -$11.3K -49,108 -75%
Creative Planning
9
Creative Planning
Kansas
$2K – – –
VFA
10
Voya Financial Advisors
Connecticut
$2K – – –
Osaic Holdings
11
Osaic Holdings
Arizona
$1K +$1.38K +6,000 New
BNP Paribas Financial Markets
12
BNP Paribas Financial Markets
France
$43 – – –
SG Americas Securities
13
SG Americas Securities
New York
– -$20K -59,203 Closed
Wells Fargo
14
Wells Fargo
California
– -$9K -26,750 Closed
Citigroup
15
Citigroup
New York
– -$2K -4,650 Closed
JP Morgan Chase
16
JP Morgan Chase
New York
– -$1K -3,167 Closed
Morgan Stanley
17
Morgan Stanley
New York
– -$9 -39 -28%

ZOM Hedge Fund Activity: Q1 2020 in Review

16 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Zomedica Corp. (ZOM) for Q1 2020, worth a combined $2.43M — down 42% from $4.21M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of ZOM and 2 opened new positions — a net loss of 4 holders — while 4 trimmed existing stakes and 3 added.

The largest buyer was Cambridge Investment Research Advisors, adding an estimated $41.7K. The largest seller was SG Americas Securities, exiting entirely with an estimated $20K sold.

  • 16 institutional investors held Zomedica Corp. (ZOM) as of Q1 2020, down from 21 in Q4 2019.
  • Funds reported $2.43M of Zomedica Corp. stock for Q1 2020, down 42% quarter-over-quarter.
  • 2 funds opened new Zomedica Corp. positions in Q1 2020 and 6 closed out, a net change of -4 holders.
  • The largest Zomedica Corp. buyer in Q1 2020 was Cambridge Investment Research Advisors, an estimated $41.7K added.
  • The largest Zomedica Corp. seller in Q1 2020 was SG Americas Securities, an estimated $20K sold.

Based on aggregated 13F filings for Q1 2020.